Levemir and Viith nerve paralysis - a phase IV clinical study of FDA data

Summary:

Viith nerve paralysis is reported as a side effect among people who take Levemir (insulin detemir recombinant), especially for people who are female, 60+ old, also take Tramadol, and have Pain.

The phase IV clinical study analyzes which people have Viith nerve paralysis when taking Levemir. It is created by eHealthMe based on reports of 13,520 people who have side effects when taking Levemir from the FDA, and is updated regularly.

What is Levemir?

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,850 Levemir users. Check the latest studies of Levemir.

What is Viith nerve paralysis?

Viith nerve paralysis is found to be associated with 525 drugs and 837 conditions by eHealthMe. Check the latest studies of Viith nerve paralysis.

On Aug, 06, 2026

13,520 people reported to have side effects when taking Levemir.
Among them, 12 people (0.09%) have Viith nerve paralysis.

Could Levemir cause Viith nerve paralysis?

Among these 12 people:

What is the gender of people who have Viith nerve paralysis when taking Levemir? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Viith nerve paralysis when taking Levemir? *

What are other drugs people take besides Levemir? *

What are other side effects people have besides Viith nerve paralysis? *

Constipation: 3 people, 25.00%
Speech Impairment (Adult) (inability to speak (adult)): 3 people, 25.00%
Drowsiness: 2 people, 16.67%
Acute Myocardial Infarction (acute heart attack): 2 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 16.67%
Skin Abscess: 2 people, 16.67%
Fall: 2 people, 16.67%
Eye Abscess: 2 people, 16.67%
Chest Pain: 2 people, 16.67%
Electrocardiogram Q Wave Abnormal: 1 person, 8.33%

What are the existing conditions these people have? *

Pain: 3 people, 25.00%
Pain In Extremity: 2 people, 16.67%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 16.67%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 16.67%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 8.33%
Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 1 person, 8.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 8.33%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 8.33%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 8.33%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Levemir and have Viith nerve paralysis?

- Check whether Viith nerve paralysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levemir:

Levemir (13,850 reports)

Browse all side effects of Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Viith nerve paralysis:

Viith nerve paralysis (525 drugs)

Browse all the conditions that are associated with Viith nerve paralysis:

Viith nerve paralysis (837 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin detemir recombinant (the active ingredients of Levemir) and Levemir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.